This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of the MISHA Knee System (Moximed Inc.) for treatment of medial compartment knee osteoarthritis.
Publications
Hayes Publications are available through the Hayes Knowledge Center, a portal to world-class research and unbiased analyses on the clinical, financial, and risk impacts of emerging, controversial, and disruptive healthcare technologies.Every Hayes publication is developed by multidisciplinary teams of clinicians and scientists using rigorous methods grounded in internally recognized standards for systematic review and Health Technology Assessment. Learn more about these evidence resources and see sample titles below.
See below for some of our recent publications.
Revakinagene Tororetcel (Neurotech Pharmaceuticals Inc.) for Macular Telangiectasia Type 2
Revakinagene tororetcel (Neurotech Pharmaceuticals Inc.) is an investigational ocular implant that delivers sustained therapeutic doses of ciliary neurotrophic factor to the retina to slow the progression of macular telangiectasia type 2.
Vibrant System (Vibrant Gastro Inc.) for Treatment of Chronic Idiopathic Constipation
This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of the Vibrant System (Vibrant Gastro Inc.) for treatment of chronic idiopathic constipation.
Suprascapular Nerve Blockade for Treatment of Poststroke Hemiplegic Shoulder Pain
This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of suprascapular nerve blockade for treatment of poststroke hemiplegic shoulder pain.
Corvia Atrial Shunt (Corvia Medical Inc.) for Heart Failure
The Corvia Atrial Shunt (formerly the InterAtrial Shunt Device [IASD]; Corvia Medical Inc.) is a transcatheter interatrial shunt under investigation for treatment of heart failure with preserved or midrange ejection fraction.
FSYX Ocular Pressure Adjusting Pump (Balance Ophthalmics Inc.) for Open-Angle Glaucoma
The FSYX Ocular Pressure Adjusting Pump (Balance Ophthalmics Inc.) is a negative pressure eye goggle indicated for reducing intraocular pressure (IOP) during sleep in adult patients with open-angle glaucoma and IOP ≤ 21 millimeters of mercury who are currently using or have undergone another IOP-lowering treatment.
Donanemab (Kisunla; Eli Lilly and Co.) for Alzheimer Disease
Donanemab (Kisunla; Eli Lilly and Co.) is an intravenously administered amyloid beta-directed antibody indicated for the treatment of Alzheimer disease. Treatment with donanemab should be initiated in patients with mild cognitive impairment or mild dementia stage of disease.
Eladocagene Exuparvovec (PTC Therapeutics) for Aromatic L-amino Acid Decarboxylase Deficiency
Eladocagene exuparvovec (PTC Therapeutics) is an investigational gene replacement therapy administered by intraputaminal infusion for the treatment of aromatic L-amino acid decarboxylase deficiency with a severe phenotype in patients aged 18 months and older.
Lenire Bimodal Neuromodulation Device (Neuromod Devices Ltd.) for the Treatment of Tinnitus
This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of the Lenire (Neuromod Devices Ltd.) bimodal neuromodulation device for the treatment of tinnitus symptoms.
pro2cool (TecTraum Inc.) for Mild Traumatic Brain Injury
The pro2cool device is a portable head and neck cooling device under investigation for the treatment of adolescent mild traumatic brain injury (mTBI; concussion).